Clinical Trials

Papers
(The H4-Index of Clinical Trials is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)73
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial52
Endpoints for randomized controlled clinical trials for COVID-19 treatments47
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justification45
Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials24
Use of electronic recruitment methods in a clinical trial of adults with gout22
The electronic health record as a clinical trials tool: Opportunities and challenges21
COVID-19 vaccine trials: The use of active controls and non-inferiority studies21
Effectiveness of social media (Facebook), targeted mailing, and in-person solicitation for the recruitment of young adult in a diabetes self-management clinical trial20
User-centered design principles in the development of clinical research tools19
Summarising salient information on historical controls: A structured assessment of validity and comparability across studies18
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials18
Intra-cluster correlations from the CLustered OUtcome Dataset bank to inform the design of longitudinal cluster trials17
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff16
Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods16
Characteristics of available studies and dissemination of research using major clinical data sharing platforms16
0.052009105682373